Inhibition of histone deaceteylase 6 improves the ability of oncolytic herpes simplex virus type 1 to kill glioma cells, a new study indciates.
http://www.sciencedaily.com/releases/2015/10/151020191659.htm
Histone deacetylase 6 inhibition enhances oncolytic viral therapy
20 octubre 2015
Volver